Drawing for MOONLIGHT AI

USPTO serial 79368480

MOONLIGHT AI

Reviewed by CopyMark Law Group

Reg. 7601937Status 700Registered
Filing date
Status date
Registration date
Dec 17, 2024
Examiner
BLAZICH, JOAN MICHELE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MOONLIGHT AI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Steven J. Solomon

Steven J. Solomon Tucker Ellis LLP950 Main Avenue, Suite 1100Cleveland, OH 44113United States

Goods and services

ClassDescriptionStatusFirst use
009Scientific and research apparatus and instruments, namely, microscopes, automated cell counters and blood cell analyzers and biopsy devices not for medical use; apparatus and instruments for conducting, switching, transforming, accumulating, regulating and controlling the distribution or use of electricity; apparatus and instruments for sound, image and data recording, transmission, reproduction or and processing; recorded or downloadable media, namely, prerecorded CD's providing genomic information; downloadable software for database management, blank digital or and analogue recording media in the nature of blank CDs and storage media; computers and computer peripherals; downloadable software and hardware for operating medical diagnostic apparatus and instruments in the nature of blood sampling apparatus, microscopes, automated cell counters and blood cell analyzers and biopsy devices not for medical use; downloadable software for medical diagnosis in the nature of analysing blood samples for cancer; downloadable software for database management for use in the field of research and development of new medicinesACTIVE—
010Surgical, medical, dental and veterinary apparatus and instruments, namely, surgical devices and instruments; diagnostic apparatus for medical use, namely, medical diagnostic apparatus for detecting cancer; diagnostic imaging apparatus for medical use, namely, microscopy diagnostic imaging apparatus for detecting or subtyping cancer; blood testing apparatus; apparatus for taking blood; blood sampling apparatus, namely, blood sampling tubesACTIVE—
042Scientific and technological services as well as research and design services relating thereto, namely, scientific genomic research and cancer research; industrial, namely, scientific analysis, industrial research in the field of genomics and cancer, and industrial design services; quality control for others and authentication services in the field of genomics and cancer, namely, testing instruments and devices; design and development of computer hardware and software; technical support and troubleshooting, namely, diagnosing problems with diagnostic apparatus and instruments for medical use; scientific research and development for the pharmaceutical industry; pharmaceutical research and development servicesACTIVE—
044Medical services; disease diagnosis services being medical testing services relating to the diagnosis and treatment of disease; medical analysis services for the diagnosis of cancer and other diseases; medical testing services relating to disease diagnosis and treatment; RNA or DNA analysis for cancer diagnosis and prognosis, namely, DNA and RNA screening for medical purposes; remote monitoring of medical data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes; medical testing for the diagnosis and treatment of persons; providing medical information in the field of the prevention, screening, diagnosis and treatment of cancer and other diseases; medical services regarding human blood collection, treatment and processing; medical laboratory services for the analysis of blood samples taken from patientsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 4, 2025LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jun 6, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
May 22, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
May 21, 2025FIMPFINAL DISPOSITION PROCESSED—
Mar 17, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 17, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 17, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 15, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 15, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 12, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 29, 2024NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 25, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 25, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 25, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 25, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 24, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Jul 24, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 24, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 24, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 22, 2024ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jul 16, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jul 1, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 10, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 10, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 10, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 25, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 25, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 25, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 25, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 25, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 2, 2024RFNTREFUSAL PROCESSED BY IB—
Dec 8, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 8, 2023RFRRREFUSAL PROCESSED BY MPU—
Dec 5, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 4, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2023DOCKASSIGNED TO EXAMINER—
May 2, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 28, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 27, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance